Jennifer Specht, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    A2 Biotherapeutics
    Topic:
    Investigator Meeting Participant
    Date added:
    10/19/2021
    Date updated:
    02/27/2024
    Relationship end date:
    09/15/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    GE Healthcare
    Topic:
    Consultant/Advisory Board
    Date added:
    11/28/2022
    Date updated:
    02/27/2024
    Relationship end date:
    12/31/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    GSK
    Topic:
    Advisory Board
    Date added:
    11/28/2022
    Date updated:
    02/27/2024
    Relationship end date:
    12/28/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Sensei Biotherapeutics
    Topic:
    Clinical Advisory Board
    Date added:
    11/28/2022
    Date updated:
    02/27/2024
    Relationship end date:
    06/03/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Volastra Therapeutics
    Topic:
    Consultant
    Date added:
    11/28/2022
    Date updated:
    02/27/2024
    Relationship end date:
    06/04/2022
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Seattle Genetics
    Topic:
    Institutional Research Funding
    Date added:
    11/28/2022
    Date updated:
    02/27/2024
    Relationship end date:
    11/01/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Pfizer
    Topic:
    Institutional Research Funding
    Date added:
    11/28/2022
    Date updated:
    02/27/2024
    Relationship end date:
    02/28/2022
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Merck
    Topic:
    Institutional Research Grant
    Date added:
    11/28/2022
    Date updated:
    02/27/2024
    Relationship end date:
    09/01/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Xencor
    Topic:
    Institutional Research Grant
    Date added:
    11/28/2022
    Date updated:
    02/27/2024
    Relationship end date:
    02/29/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Genentech
    Topic:
    Institutional Research Grant
    Date added:
    11/28/2022
    Date updated:
    02/27/2024
    Relationship end date:
    05/13/2025

Pages

Return to Best of ASH & SABCS 2024, Seattle